Approval · Notice of Compliance 33325 · 2024
IVOZFO: Notice of Compliance 33325
Issued May 28, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33325
- Date
- May 28, 2024
- Company
- Verity Pharmaceuticals IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IVOZFO | Not yet assigned | — |
Medicinal ingredients
- FOSFOMYCIN SODIUM 2 G per VIAL
- FOSFOMYCIN SODIUM 4 G per VIAL
- FOSFOMYCIN SODIUM 8 G per VIAL